ArticleIJID regions2025
Measuring the catastrophic cost of diagnosis, treatment, care, and support on people and families affected by tuberculosis in Iran and Afghanistan.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of Patient Satisfaction with TB Care Services in Southern Afghanistan.Patient preference and adherence · 2026Article
- When injury costs too much: the catastrophic costs for spinal cord injury in Iran.BMC health services research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: A key goal of the World Health Organization's End Tuberculosis (TB) Plan was to eliminate TB-related catastrophic costs by 2030. This study aimed to measure the achievement of two countries (Iran and Afghanistan) in this plan. Design or Methods: Using a random cluster sampling, 649 patients with TB were interviewed in 2020. This study calculated the direct, indirect, and catastrophic costs for Iran and Afghanistan and applied regression estimators and a sensitivity analysis. Results: The results showed that 49% of households in Afghanistan and 20% of households in Iran faced TB-related catastrophic costs. Being in multidrug-resistant treatment (odds ratio [OR] = 3.670) was related to facing catastrophic costs. Households with a female (OR = 0.532), being an Iran resident (OR = 0.429), and being a university degree-holder (OR = 0.284) patient with TB had a lower likelihood of facing catastrophic costs. Conclusion: The findings of this study showed that these two countries are far from the goals of the World Health Organization for having zero TB-related catastrophic costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.